Discounted Cash Flow (DCF) Analysis Unlevered

OrthoPediatrics Corp. (KIDS)

$45.1

-0.30 (-0.66%)
All numbers are in Millions, Currency in USD
Stock DCF: -69.52 | 45.1 | overvalue

Operating Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 45.6257.5672.5571.0898.05119.65146.02178.19217.45265.36
Revenue (%)
EBITDA -4.04-6.88-5.52-22.25-4.46-15.38-18.76-22.90-27.94-34.10
EBITDA (%)
EBIT -6.44-9.77-10.19-30.26-15.14-24.68-30.12-36.76-44.86-54.74
EBIT (%)
Depreciation 2.412.894.678.0110.689.3111.3613.8616.9220.64
Depreciation (%)

Balance Sheet Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 42.5860.6970.7883.9053.54112.23136.96167.13203.96248.90
Total Cash (%)
Account Receivables 5.609.5016.5717.5517.9422.6427.6333.7241.1550.21
Account Receivables (%)
Inventories 20.5425.713852.9957.5765.8980.4198.12119.74146.13
Inventories (%)
Accounts Payable 5.503.976.4710.049.3312.3215.0418.3522.3927.33
Accounts Payable (%)
Capital Expenditure -6.54-5.46-12.09-11.30-8.10-15.47-18.88-23.04-28.12-34.31
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 45.1
Beta 0.858
Diluted Shares Outstanding 19.29
Cost of Debt
Tax Rate 6.49
After-tax Cost of Debt 231.67%
Risk-Free Rate
Market Risk Premium
Cost of Equity 8.016
Total Debt 0.91
Total Equity 870.04
Total Capital 870.95
Debt Weighting 0.10
Equity Weighting 99.90
Wacc

Build Up Free Cash

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 45.6257.5672.5571.0898.05119.65146.02178.19217.45265.36
EBITDA -4.04-6.88-5.52-22.25-4.46-15.38-18.76-22.90-27.94-34.10
EBIT -6.44-9.77-10.19-30.26-15.14-24.68-30.12-36.76-44.86-54.74
Tax Rate 0.00%0.00%-8.25%2.15%6.49%0.08%0.08%0.08%0.08%0.08%
EBIAT -6.44-9.77-11.03-29.61-14.16-24.67-30.10-36.73-44.83-54.70
Depreciation 2.412.894.678.0110.689.3111.3613.8616.9220.64
Accounts Receivable --3.90-7.07-0.98-0.39-4.70-4.99-6.09-7.43-9.07
Inventories --5.16-12.29-14.99-4.58-8.32-14.52-17.72-21.62-26.38
Accounts Payable --1.522.503.57-0.7132.713.314.044.93
Capital Expenditure -6.54-5.46-12.09-11.30-8.10-15.47-18.88-23.04-28.12-34.31
UFCF -10.58-22.93-35.31-45.30-17.27-40.85-54.41-66.40-81.03-98.89
WACC
PV UFCF -37.74-46.44-52.35-59.01-66.53
SUM PV UFCF -262.07

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 8.25
Free cash flow (t + 1) -100.87
Terminal Value -1,613.86
Present Value of Terminal Value -1,085.74

Intrinsic Value

Enterprise Value -1,347.81
Net Debt -6.73
Equity Value -1,341.08
Shares Outstanding 19.29
Equity Value Per Share -69.52